Demand of Aspirin, BIO-11006, and Dopamine Drugs to be Boosted by Long Term Covid-19 Health Effects

In May 2020, total number of COVID-19 cases crossed a mark of 5 million of which, approximately 1.3 million cases are listed as recovered. However, experts are warning of possible long-term effects for patients after they’ve survived the corona disease. This disease attacks many organs within the body — from the lungs and heart, to the liver and kidneys. In addition, there are also, few instances of mental disorder after recovery such as post-traumatic stress disorder (PTSD), chronic fatigue, depression, and anxiety. These effects increased the demand for medicines in chronic categories and gave a major boost to the overall medical industry including pharmaceuticals and medical devices across various countries globally.